Irit Reichenstein is a senior scientist currently at Anima Biotech, where they apply their extensive expertise in genetics, animal models, and cellular and molecular biology. Previously, they worked at GliXogen Therapeutics from 2019 to 2022 and completed a postdoctoral fellowship at the Weizmann Institute of Science from 2011 to 2017. Irit holds a Ph.D. in Molecular Genetics, a Master’s Degree in Molecular Biology, and a Bachelor’s Degree in Biology, all from the Weizmann Institute and Ben-Gurion University of the Negev. Notably, they successfully led a study that identified a motor neuron-specific microRNA and its significance in human motor neuron disease.
This person is not in any offices